GlassScriptPhysician profile
Danielle Lind Ward
NPI 1346680352
$1,485.92
in general payments reported to CMS, 2019-2025
22 companies · $56.03 in 2025
The $56.03 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $864 · 2022: $304 · 2023: $143 · 2024: $119 · 2025: $56.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $318.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $223.07 | 2021-2022 | |
| Polynovo North America LLC | $174.92 | 2024-2025 | Novosorb Btm |
| Sientra, INC. | $135.94 | 2022 | |
| Boston Scientific Corporation | $117.22 | 2023 | Watchman Flx |
| Amgen INC. | $109.43 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $100.30 | 2021 | |
| Janssen Pharmaceuticals, INC | $96.55 | 2021-2023 | Xarelto |
| Sanofi-Aventis U.S. LLC | $72.78 | 2021 | |
| Esperion Therapeutics, INC. | $68.19 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $49.55 | 2021 | |
| Novartis Pharmaceuticals Corporation | $44.51 | 2021 | |
| Pfizer INC. | $43.28 | 2021 | |
| Merck Sharp & Dohme LLC | $40.46 | 2021 | |
| Lundbeck LLC | $40.32 | 2021 | |
| Arbor Pharmaceuticals, INC. | $30.45 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.28 | 2021 | |
| Currax Pharmaceuticals LLC | $27.14 | 2021 | |
| Impulse Dynamics (USA) INC. | $22.93 | 2022 | |
| Novo Nordisk INC | $18.69 | 2021 | |
| Lilly USA, LLC | $14.00 | 2021 | |
| Amarin Pharma, INC. | $13.49 | 2021 | |
| Sobi, INC | $13.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Lind Ward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.